These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 12745272

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T.
    Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
    Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C.
    Am J Pathol; 1998 Dec 15; 153(6):1749-65. PubMed ID: 9846966
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets.
    Ghimenti C, Fiano V, Chiadò-Piat L, Chiò A, Cavalla P, Schiffer D.
    J Neurooncol; 2003 Jan 15; 61(2):95-102. PubMed ID: 12622447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.
    Fulci G, Labuhn M, Maier D, Lachat Y, Hausmann O, Hegi ME, Janzer RC, Merlo A, Van Meir EG.
    Oncogene; 2000 Aug 03; 19(33):3816-22. PubMed ID: 10949938
    [Abstract] [Full Text] [Related]

  • 10. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
    Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP.
    Cancer Res; 2000 Jan 15; 60(2):417-24. PubMed ID: 10667596
    [Abstract] [Full Text] [Related]

  • 11. Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma.
    Møller MB, Ino Y, Gerdes AM, Skjødt K, Louis DN, Pedersen NT.
    Leukemia; 1999 Mar 15; 13(3):453-9. PubMed ID: 10086736
    [Abstract] [Full Text] [Related]

  • 12. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets.
    Cui Y, Han L, Shang J, Fang W, Zhao M, Chen D, Liu H.
    Hum Pathol; 2022 May 15; 123():113-122. PubMed ID: 35181378
    [Abstract] [Full Text] [Related]

  • 13. p53 and mdm2 in mantle cell lymphoma in leukemic phase.
    Solenthaler M, Matutes E, Brito-Babapulle V, Morilla R, Catovsky D.
    Haematologica; 2002 Nov 15; 87(11):1141-50. PubMed ID: 12414343
    [Abstract] [Full Text] [Related]

  • 14. Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation.
    Pruneri G, Carboni N, Baldini L, Intini D, Colombi M, Bertolini F, Valentini S, Maisonneuve P, Viale G, Neri A.
    Hum Pathol; 2003 Jan 15; 34(1):41-7. PubMed ID: 12605365
    [Abstract] [Full Text] [Related]

  • 15. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, Liu C, Lombari V, Zani M, Giannini G, Gagliardi FM, Caruso R, Gulino A, Frati L, Ragona G.
    Clin Cancer Res; 2001 Sep 15; 7(9):2788-96. PubMed ID: 11555594
    [Abstract] [Full Text] [Related]

  • 16. TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe.
    Tanière P, Martel-Planche G, Saurin JC, Lombard-Bohas C, Berger F, Scoazec JY, Hainaut P.
    Br J Cancer; 2001 Sep 01; 85(5):721-6. PubMed ID: 11531258
    [Abstract] [Full Text] [Related]

  • 17. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
    Faderl S, Kantarjian HM, Manshouri T, Chan CY, Pierce S, Hays KJ, Cortes J, Thomas D, Estrov Z, Albitar M.
    Clin Cancer Res; 1999 Jul 01; 5(7):1855-61. PubMed ID: 10430092
    [Abstract] [Full Text] [Related]

  • 18. Genetic profile of gliosarcomas.
    Reis RM, Könü-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H.
    Am J Pathol; 2000 Feb 01; 156(2):425-32. PubMed ID: 10666371
    [Abstract] [Full Text] [Related]

  • 19. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 01; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 20. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
    Semczuk A, Marzec B, Skomra D, Roessner A, Cybulski M, Rechberger T, Schneider-Stock R.
    Oncology; 2005 Apr 01; 69(4):317-25. PubMed ID: 16293976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.